Fibroblast Growth Factor 23 in Chronic Respiratory Failure

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2023

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions

Chronic Respiratory Failure

Interventions

OTHER

Dosage

Evaluation of circulating C-terminal FGF23 (FGF23Ct) rate, circulating intact FGF23 (FGF23i) rate and Erythropoietin

OTHER

Cardiac echography

12 months after patient enrollment

All Listed Sponsors

collaborator

Fondation Université de Paris

UNKNOWN

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT05258370 - Fibroblast Growth Factor 23 in Chronic Respiratory Failure | Biotech Hunter | Biotech Hunter